pharma

AstraZeneca Seeks Edge Over Rivals in Severe Asthma Treatment

By Ben Hirschler LONDON – AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months. The drugmaker has previously flagged benralizumab, which is likely to reach the market next year,

[ Read More ]

Japan Warns Brexit May Drive Banks, Pharma Investment to EU

TOKYO, Sept 4  – Japan has warned Britain that its exit from the European Union could prompt Japanese financial institutions to relocate from London and listed a raft of concerns from Japanese companies about the transition away of the EU. In a 15-page report published on the eve of a summit of the Group of

[ Read More ]

New Incentives Needed to Develop Antibiotics to Fight Superbugs

By Bill Berkrot NEW YORK, May 29 – Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment, companies and industry experts said. American military researchers on Thursday

[ Read More ]

Pharma Crusader Takes India’s Drug Regulators to Court

By Zeba Siddiqui NEW DELHI, March 7 – One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion industry. Three years ago, Dinesh Thakur exposed how India’s

[ Read More ]